Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Accelerate Diagnostics stock in Canada | $7.59
Own Accelerate Diagnostics shares in just a few minutes.
Accelerate Diagnostics is a diagnostics & research business based in the US. Accelerate Diagnostics stocks (AXDX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $7.19 – an increase of 10.16% over the previous week. Accelerate Diagnostics employs 224 staff and has a trailing 12-month revenue of around $11.3 million.
How to buy Accelerate Diagnostics stock in Canada
- Choose a platform. If you're a beginner, our stock trading table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: AXDX in this case.
- Research Accelerate Diagnostics stocks. The platform should provide the latest information available.
- Buy your Accelerate Diagnostics stocks. It's that simple.
What's in this guide?
- Can I buy shares in Accelerate Diagnostics?
- Has coronavirus impacted Accelerate Diagnostics shares?
- Accelerate Diagnostics shares summary
- Compare share dealing platforms
- Is Accelerate Diagnostics stock a buy or sell?
- Accelerate Diagnostics performance over time
- Can I short Accelerate Diagnostics shares?
- Accelerate Diagnostics's financials
- How volatile are Accelerate Diagnostics shares?
- Does Accelerate Diagnostics pay a dividend?
- Other common questions
How has Coronavirus impacted Accelerate Diagnostics's stock price?
Since the stock market crash in March caused by coronavirus, Accelerate Diagnostics's stock price has had significant negative movement.
Its last market close was $7.59, which is 52.94% down on its pre-crash value of $16.13 and 67.55% up on the lowest point reached during the March crash when the stocks fell as low as $4.53.
If you had bought $1,000 worth of Accelerate Diagnostics stocks at the start of February 2020, those stocks would have been worth $346.61 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $443.64.
Accelerate Diagnostics stock priceUse our graph to track the performance of AXDX stocks over time.
Accelerate Diagnostics stocks at a glance
|Latest market close||$7.59|
|52-week range||$6.44 - $17.82|
|50-day moving average||$7.7686|
|200-day moving average||$8.7843|
|Wall St. target price||$13|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.599|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Accelerate Diagnostics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Accelerate Diagnostics price performance over time
|1 month (2021-07-02)||-4.53%|
|3 months (2021-04-30)||3.83%|
Accelerate Diagnostics financials
|Revenue TTM||USD$11.3 million|
|Gross profit TTM||USD$4.5 million|
|Return on assets TTM||-38.56%|
|Return on equity TTM||0%|
|Market capitalisation||USD$442 million|
TTM: trailing 12 months
How to short and sell Accelerate Diagnostics stocks
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "AXDX.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 7.8 million Accelerate Diagnostics stocks held short by investors – that's known as Accelerate Diagnostics's "short interest". This figure is 0.9% up from 7.8 million last month.
There are a few different ways that this level of interest in shorting Accelerate Diagnostics stocks can be evaluated.
Accelerate Diagnostics's "short interest ratio" (SIR)
Accelerate Diagnostics's "short interest ratio" (SIR) is the quantity of Accelerate Diagnostics stocks currently shorted divided by the average quantity of Accelerate Diagnostics stocks traded daily (recently around 175474.16032244). Accelerate Diagnostics's SIR currently stands at 44.66. In other words for every 100,000 Accelerate Diagnostics stocks traded daily on the market, roughly 44660 stocks are currently held short.
However Accelerate Diagnostics's short interest can also be evaluated against the total number of Accelerate Diagnostics stocks, or, against the total number of tradable Accelerate Diagnostics stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Accelerate Diagnostics's short interest could be expressed as 0.13% of the outstanding stocks (for every 100,000 Accelerate Diagnostics stocks in existence, roughly 130 stocks are currently held short) or 0.2832% of the tradable stocks (for every 100,000 tradable Accelerate Diagnostics stocks, roughly 283 stocks are currently held short).
A SIR above 20% would generally be considered very high, pointing to a pessimistic outlook for the stock price, with a discouraging number of investors currently willing to bet against Accelerate Diagnostics.
Find out more about how you can short Accelerate Diagnostics stock.
Accelerate Diagnostics stock dividends
We're not expecting Accelerate Diagnostics to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.
Accelerate Diagnostics stock price volatility
Over the last 12 months, Accelerate Diagnostics's stocks have ranged in value from as little as $6.44 up to $17.82. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Accelerate Diagnostics's is 1.9581. This would suggest that Accelerate Diagnostics's stocks are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Accelerate Diagnostics overview
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in Tucson, Arizona.
Stocks similar to Accelerate Diagnostics
Accelerate Diagnostics in the news
This In Vitro Diagnostics Company Is Poised to Capture Its Share of a Growing Market
Accelerate Diagnostics (AXDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Insider Weekends: William Furman Steps Up His Purchases Of Greenbrier
Frequently asked questions
More guides on Finder
How to buy Wheels Up (UP) stock in Canada when it goes public
Everything we know about the Wheels Up IPO, plus information on how to buy in.
How to buy Brookfield Asset Management Reinsurance Partners Ltd (BAMR) stock in Canada when it goes public
Everything we know about the Brookfield Asset Management Reinsurance Partners Ltd IPO, plus information on how to buy in.
How to buy Traeger (COOK) stock in Canada when it goes public
Everything we know about the Traeger IPO, plus information on how to buy in.
How to buy Teads (TEAD) stock in Canada when it goes public
Everything we know about the Teads IPO, plus information on how to buy in.
How to buy Snap One Holdings Corp (SNPO) stock in Canada
Everything we know about the Snap One Holdings Corp IPO, plus information on how to buy in.
How to buy Riskified (RSKD) stock in Canada
Everything we know about the Riskified IPO, plus information on how to buy in.
How to buy Preston Hollow Community Capital (PHCC) stock in Canada when it goes public
Everything we know about the Preston Hollow Community Capital IPO, plus information on how to buy in.
How to buy PowerSchool Holdings (PWSC) stock in Canada
Everything we know about the PowerSchool Holdings IPO, plus information on how to buy in.
How to buy MeridianLink (MLNK) stock in Canada
Everything we know about the MeridianLink IPO, plus information on how to buy in.
How to buy Dole (DOLE) stock in Canada when it goes public
Everything we know about the Dole IPO, plus information on how to buy in.